So, who exactly, is 'insinuating' that FDA approval is just around the corner. Or have you invented that for your own purposes?
Plus, who don't you present an informed analysis of the recent experience with Orphan drug approval timelines - something useful - rather than just plucking irrelevant comparisons out of the air. Shouldn't be too difficult.
DXB Chart, page-1060
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $242.0M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.5¢ | 44.0¢ | $1.428M | 3.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 109582 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 21213 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |